comparemela.com

Latest Breaking News On - Skin and soft tissue infection - Page 8 : comparemela.com

Experimental Tx Restores Cognitive Function in Chronic TBI

In a first-in-humans trial, deep brain stimulation restored executive function in five individuals with moderate to severe traumatic brain injury 3-18 years after injury.

United statesStanford universityNew yorkJaimie hendersonJimmy yangJavier cardenasNicholas schiffOhio state university college of medicineRockefeller neuroscience institutionVirginia universityWeill cornell medical collegeBrain injury centerStanford university college of medicineNew york cityMedscape medicalStanford university college

Meta-Analysis: Suicide Risk Not Increased With Isotretinoin

In fact, those treated with the drug for severe acne may have a lower risk for suicide attempts 2-4 years after treatment, according to the study authors.

United statesNational university of singaporeSingapore generalUniversity of adelaideSouth australiaEli lillyParker maginShaun prenticeNicole kye wenJohns barbieriYong loo lin school of medicineBoehringer ingelheimPublic healthFaculty of healthSchool of medicineUniversity of newcastle

Pilonidal Disease: Study Finds Laser Hair Removal Beneficial

The study compared laser epilation plus standard of care with standard care alone for patients aged 11-20 years with pilonidal disease.

Facial rejuvenationAesthetic medicineSkin and soft tissue infectionLaser hair removalAser assisted hair removalPilonidal diseaseDisease recurrenceDherence to medication issues for patientsAdolescent medicineYoung adult

At 52 Weeks, Hair Growth Still Climbing on Deuruxolitinib

With response curves still climbing at follow-up to date, the results are truly, truly remarkable.

United statesBoston universityLynne goldbergBrett kingEuropean academy of dermatologyAmerican academy of dermatologyYale universityConcert pharmaceuticalsBoston medical centerEuropean academyNew havenAmerican academyAlopecia toolSkin and soft tissue infectionHair growthAlopecia areata

HS: Positive Results Reported With Anti-IL17A/F Therapies

One of the trials evaluated a nanobody inhibitor, sonelokimab, a molecule with a substantially smaller size than traditional monoclonal antibodies.

United statesBrandenburg medical schoolEuropean unionDrug administrationHidradenitis suppurativaSkin and soft tissue infectionBiologic therapyMonoclonal antibodyOral healthOral medicineMental healthRural healthcareRural health carePsoriatic arthritisRthropathic psoriasisPsoriatic arthropathy

vimarsana © 2020. All Rights Reserved.